Clinical Trial Update: Autologous Stem Cell Transplantation for Myeloma Patients Over 65 Years

View source ↗

Summary

Clinical trial update on autologous stem cell transplantation for newly diagnosed multiple myeloma patients over 65; current status of the trial is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Newly Diagnosed Myeloma Patient Above 65 Years Old | Status: UNKNOWN